trending Market Intelligence /marketintelligence/en/news-insights/trending/eoh01m2pnoyqmn82hwcwrq2 content esgSubNav
In This List

Zafgen appoints board member; 2 directors retire

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Zafgen appoints board member; 2 directors retire

Zafgen Inc. added Wendy Everett to its board.

Everett currently serves as special adviser to Network for Excellence in Health Innovation, a Boston-based nonprofit nonpartisan research and policy organization. She was also formerly the organization's CEO and president.

Additionally, the company announced the retirement of Bruce Booth and Frances Heller from the board.

Zafgen said Heller's and Booth's departures were not due to any disagreement with the company on any matters relating to its operations, policies or practices.

Boston-based Zafgen develops therapies to treat metabolic diseases such as type 2 diabetes and Prader-Willi syndrome, a genetic disorder caused by the loss of function of specific genes.